Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer
- Conditions
- Gastric CancerPancreatic CancerBiliary CancerColorectal Cancer
- First Posted Date
- 2016-09-21
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- AbGenomics B.V Taiwan Branch
- Target Recruit Count
- 39
- Registration Number
- NCT02908451
- Locations
- 🇺🇸
Mayo Clinic, Phoenix, Arizona, United States
🇺🇸University of California, San Francisco, California, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD
- Conditions
- Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation
- First Posted Date
- 2016-03-01
- Last Posted Date
- 2016-04-25
- Lead Sponsor
- AbGenomics B.V Taiwan Branch
- Registration Number
- NCT02694770
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant
- Conditions
- Acute Graft Versus Host Disease
- First Posted Date
- 2015-05-06
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- AbGenomics B.V Taiwan Branch
- Target Recruit Count
- 4
- Registration Number
- NCT02436460
- Locations
- 🇺🇸
Stanford University, School of Medicine, Stanford, California, United States
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
- Conditions
- Psoriatic Arthritis
- First Posted Date
- 2014-10-17
- Last Posted Date
- 2017-01-24
- Lead Sponsor
- AbGenomics B.V Taiwan Branch
- Target Recruit Count
- 20
- Registration Number
- NCT02267642
- Locations
- 🇺🇸
UC San Diego, La Jolla, California, United States
🇺🇸Stanford University, Palo Alto, California, United States
🇺🇸Sarasota Arthritis Research Center, Sarasota, Florida, United States
A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis
- Conditions
- Moderate to Severe Chronic Plaque Psoriasis
- First Posted Date
- 2014-08-22
- Last Posted Date
- 2016-04-14
- Lead Sponsor
- AbGenomics B.V Taiwan Branch
- Target Recruit Count
- 50
- Registration Number
- NCT02223039
- Locations
- 🇺🇸
Alliance Dermatology & MOHS Center, PC, Phoenix, Arizona, United States
🇺🇸Northwest AR Clinical Trials Center, PLLC., Rogers, Arkansas, United States
🇺🇸Renstar Medical Research, Ocala, Florida, United States
- Prev
- 1
- 2
- Next